Earnings
|
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Thermo Fisher (TMO), consensus $5.19... T-Mobile (TMUS), consensus $1.10... Altria (MO), consensus $1.17... Boston Scientific (BSX), consensus 47c... Humana (HUM), consensus $1.46... AmerisourceBergen (ABC), consensus $2.63... Fortive (FTV), consensus 84c... Dynatrace (DT), consensus 21c... Peloton (PTON), consensus (64c)... Brinker (EAT), consensus 52c. ShowHide Related Items >><< - 01/19/23
- T-Mobile says it may incur 'significant expenses' over cyber incident
- 01/09/23
- Siyata Mobile to launch SD7 device across T-Mobile IoT data network
- 01/05/23
- Delta, T-Mobile to partner on free in-flight Wi-Fi for SkyMiles members
- 12/28/22
- Voip-Pal.com announces PTAB denies institution of four IPR petitions
- $563.16 /
-0.905 (-0.16%) - 01/24/23
- Thermo Fisher, AstraZeneca team on CDx test for Tagrisso
- 01/12/23
- Thermo Fisher joins Momentum Labs as a founding sponsor of biotech hub
- 01/03/23
- Thermo Fisher completes acquisition of The Binding Site Group, sees accretion
- 01/03/23
- Aslan, Thermo Fisher announce partnership for manufacturing eblasakimab
- 01/17/23
- Peloton appoints Leslie Berland as CMO
- 01/09/23
- Verizon offers four months of Peloton app free through +play beta
- 01/05/23
- Peloton to pay $19M civil penalty for failure to immediately report hazards
- 12/26/22
- Peloton to offer refurbished bikes with Peloton Certified Refurbished
- 01/24/23
- Altria Group trading resumes
- 01/24/23
- Altria Group trading halted, volatility trading pause
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 12/19/22
- Cronos Group receives notice of relinquishment of warrant by Altria Group
- $508.55 /
+23.49 (+4.84%) - 01/12/23
- Evolent Health jumps after announcing expansion of Humana pact
- 01/09/23
- Rite Aid appoints Elizabeth Burr as interim CEO
- 12/22/22
- Humana wins Defense Department TRICARE East Region Contract
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 11/02/22
- Brinker reports Q1 system-wide comparable restaurant sales growth 5.5%
- 10/25/22
- Brinker announces executive leadership changes
- 08/24/22
- Brinker: Q1 likely to be low point of operating results for FY23
- 08/24/22
- Brinker says 'mid-teens' restaurant margins achievable
- 11/02/22
- Dynatrace under pressure following Q2 beat, 2023 guidance cut
- 11/02/22
- Dynatrace names Jim Benson as CFO, succeeding Kevin Burns
- 10/27/22
- DXC Technology announces expanded partnership with Dynatrace
- 09/19/22
- Dynatrace to replace American Eagle in S&P 400 at open on 9/19
- 01/11/23
- Boston Scientific targeting 'double digit' EPS growth in 2023, consensus $1.93
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 12/11/22
- Boston Scientific to acquire majority stake of Acotec Scientific
- 11/29/22
- Apollo Endosurgery to be acquired by Boston Scientific for $10.00 per share
- $167.82 /
+2.435 (+1.47%) - 01/24/23
- AmerisourceBergen to change name to Cencora
- 01/24/23
- AmerisourceBergen plans to change name to Cencora
- 12/30/22
- AmerisourceBergen calls DOJ complaint 'an attempt to shift blame' from DEA
- 12/29/22
- Justice Department files civil complaint against AmerisourceBergen over opioids
- $563.16 /
-0.905 (-0.16%) - 01/24/23 Barclays
- Thermo Fisher price target raised to $630 from $570 at Barclays
- 01/03/23 Wells Fargo
- Thermo Fisher price target lowered to $505 from $525 at Wells Fargo
- 12/13/22 Deutsche Bank
- Thermo Fisher initiated with a Buy at Deutsche Bank
- 12/06/22 RBC Capital
- Thermo Fisher initiated with an Outperform at RBC Capital
- 01/17/23 KeyBanc
- Cogent price target raised to $71 from $64 at KeyBanc
- 01/13/23 Truist
- American Tower price target lowered to $275 from $325 at Truist
- 01/05/23 JPMorgan
- T-Mobile remains a top pick after preannouncement at JPMorgan
- 01/03/23 Wolfe Research
- T-Mobile downgraded to Peer Perform from Outperform at Wolfe Research
- 11/10/22 UBS
- UBS downgrades Altria to Sell on consumer trade down risk
- 11/10/22 UBS
- Altria Group downgraded to Sell from Neutral at UBS
- 11/02/22 Morgan Stanley
- Philip Morris price target raised to $109 from $102 at Morgan Stanley
- 10/28/22 Stifel
- Altria JV news trumps 'rare' EPS miss, says Stifel
- 01/04/23 Barclays
- Boston Scientific price target raised to $53 from $49 at Barclays
- 01/03/23 Stifel
- Apollo Endosurgery downgraded to Hold from Buy at Stifel
- 12/22/22 Mizuho
- Boston Scientific initiated with a Neutral at Mizuho
- 12/20/22 Citi
- Boston Scientific resumed with a Buy at Citi
- $508.55 /
+23.49 (+4.84%) - 07:09 Today JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 01/30/23 Cowen
- Evolent Health price target raised to $59 from $57 at Cowen
- 12/27/22 Piper Sandler
- Piper views TriCare T-5 contract awards as neutral for Accolade
- 12/23/22 Wells Fargo
- Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
- $167.82 /
+2.435 (+1.47%) - 08:17 Today UBS
- AmerisourceBergen price target raised to $190 from $184 at UBS
- 06:33 Today Evercore ISI
- AmerisourceBergen resumed with an Outperform at Evercore ISI
- 01/12/23 Argus
- AmerisourceBergen price target raised to $190 from $170 at Argus
- 01/11/23 Baird
- AmerisourceBergen price target raised to $199 from $195 at Baird
- 01/13/23 Mizuho
- Fortive price target raised to $63 from $60 at Mizuho
- 12/09/22 Citi
- Fortive price target raised to $77 from $73 at Citi
- 10/12/22 Morgan Stanley
- Fortive upgraded to Overweight at Morgan Stanley on execution, resilience
- 10/12/22 Morgan Stanley
- Fortive upgraded to Overweight from Equal Weight at Morgan Stanley
- 01/10/23 Barclays
- Dynatrace downgraded to Equal Weight from Overweight at Barclays
- 01/09/23 Truist
- Dynatrace price target lowered to $45 from $50 at Truist
- 01/03/23 Wells Fargo
- Dynatrace price target raised to $50 from $45 at Wells Fargo
- 12/15/22 Wedbush
- Wedbush initiates Dynatrace with a Neutral and $35 price target
- 01/30/23 Citi
- Peloton promotions drove improved traffic trends, says Citi
- 01/24/23 MKM Partners
- MKM Partners positive on Peloton heading into earnings
- 01/24/23 Baird
- Peloton downgraded to Neutral from Outperform at Baird
- 11/21/22 Cowen
- Peloton downgraded to Market Perform from Outperform at Cowen
- 01/24/23 Deutsche Bank
- Brinker price target raised to $38 from $34 at Deutsche Bank
- 01/05/23 Barclays
- Brinker price target lowered to $30 from $31 at Barclays
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/12/22 Goldman Sachs
- Brinker downgraded to Sell from Neutral at Goldman Sachs
- 01/04/23
- T-Mobile sees FY22 postpaid net customer additions 6.4M
- 01/04/23
- T-Mobile sees Q4 postpaid net customer additions 1.8M
- 10/27/22
- T-Mobile raise FY22 core adjusted EBITDA view to $26.2B-$26.4B from $26B-$26.3B
- 10/27/22
- T-Mobile reports Q3 EPS 40c, consensus 4c
- $563.16 /
-0.905 (-0.16%) - 10/26/22
- Thermo Fisher raises FY22 EPS view to $23.01 from $22.93, consensus $22.95
- 10/26/22
- Thermo Fisher reports Q3 adjusted EPS $5.08, consensus $4.82
- 10/25/22
- Notable companies reporting before tomorrow's open
- 11/03/22
- Peloton sees Q2 revenue $700M-$725M, consensus $874M
- 11/03/22
- Peloton reports Q1 EPS ($1.20), consensus (64c)
- 11/02/22
- Notable companies reporting before tomorrow's open
- 10/27/22
- Altria Group narrows FY22 EPS view to $4.81-$4.89, consensus $4.85
- 10/27/22
- Altria Group reports Q3 adjusted EPS $1.28, consensus $1.30
- $508.55 /
+23.49 (+4.84%) - 11/02/22
- Humana backs FY22 adjusted EPS view 'approximately $25.00,' consensus $25.03
- 11/02/22
- Humana reports Q3 adjusted EPS $6.88, consensus $6.28
- 11/01/22
- Notable companies reporting before tomorrow's open
- 10/26/22
- Fortive narrows FY22 adjusted EPS view to $3.10-$3.13 from $3.07-$3.13
- 10/26/22
- Fortive sees Q4 adjusted EPS 82c-85c, consensus 86c
- 10/26/22
- Fortive reports Q3 adjusted EPS 79c, consensus 76c
- 11/02/22
- Brinker reports Q1 EPS (57c) ex-items, consensus (60c)
- 08/24/22
- Brinker sees FY23 adjusted EPS $2.45-$2.85, consensus $3.65
- 08/24/22
- Brinker reports Q4 adjusted EPS $1.15, consensus $1.15
- 11/02/22
- Dynatrace reports Q3 non-GAAP EPS 22c, consensus 18c
- 08/03/22
- Dynatrace lowers FY23 non-GAAP EPS view to 73c-76c from 74c-77c, consensus 77c
- 10/26/22
- Boston Scientific cuts FY22 adjusted EPS view to $1.71-$1.74 from $1.74-$1.77
- 10/26/22
- Boston Scientific sees Q4 adjusted EPS 45c-48c, consensus 49c
- 10/26/22
- Boston Scientific reports Q3 EPS 43c, consensus 44c
- $167.82 /
+2.435 (+1.47%) - 11/03/22
- AmerisourceBergen sees FY23 adjusted EPS $11.30-$11.60, consensus $11.45
- 11/03/22
- AmerisourceBergen reports Q4 adjusted EPS $2.60, consensus $2.57
- 08/03/22
- AmerisourceBergen raises FY22 adjusted EPS view to $10.90-$11.10
- 08/03/22
- AmerisourceBergen reports Q3 adjusted EPS $2.62, consensus $2.56
|
Recommendations
| ShowHide Related Items >><< - $485.76 /
-0.035 (-0.01%) - 01/19/23
- UnitedHealth expands health offerings with virtual behavioral coaching
- 01/13/23
- UnitedHealth: OptumRx revenues grew 9%, approaching $100B in FY22
- 01/13/23
- UnitedHealth expects to have more than 750 community pharmacies by 2023E
- 01/13/23
- UnitedHealth backs FY23 cash flow from operations view $27B-$28B
- 01/03/23
- Molina Healthcare to double California revenue with Medi-Cal contracts in 2024
- 12/29/22
- Molina Healthcare to record $200M impairment charge in Q4 on leased space
- 09/26/22
- Molina Healthcare selected for Nebraska Medicaid program
- 08/31/22
- Molina Healthcare wins Iowa Medicaid contract
- 01/12/23
- Evolent Health jumps after announcing expansion of Humana pact
- 01/09/23
- Rite Aid appoints Elizabeth Burr as interim CEO
- 12/22/22
- Humana wins Defense Department TRICARE East Region Contract
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 01/26/23
- Medavail to sell certain SpotRx pharmacy assets to CVS Health
- 01/23/23
- CVS Health names Bricker CPO, Joyner rejoins as pharmacy services president
- 01/17/23
- Oak Street Health down 7% in afternoon trading
- 01/12/23
- CVS Health names Sam Khichi Chief Policy Officer and General Counsel
- 01/23/23
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
- 01/03/23
- Centene's Health Net selected for new medi-cal direct contracts
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 12/14/22
- Centene announces new leadership appointments
- $310.37 /
+2.085 (+0.68%) - 01/12/23
- California AG files suit against drugmakers, PBMs over insulin prices
- 12/06/22
- Walmart to pay $500,000 over workers' compensation prescription procedures
- 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 10/25/22
- Cigna's Express Scripts partners with Centene for prescription benefits
- 12/23/22 Wells Fargo
- Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
- 12/23/22 Credit Suisse
- TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 12/13/22 BofA
- Centene downgraded to Underperform from Neutral at BofA
- 01/30/23 Cowen
- Evolent Health price target raised to $59 from $57 at Cowen
- 12/27/22 Piper Sandler
- Piper views TriCare T-5 contract awards as neutral for Accolade
- $485.76 /
-0.035 (-0.01%) - 01/24/23 Deutsche Bank
- UnitedHealth price target raised to $617 from $615 at Deutsche Bank
- 01/18/23 UBS
- UnitedHealth price target lowered to $550 from $590 at UBS
- 01/17/23 Loop Capital
- UnitedHealth price target raised to $590 from $575 at Loop Capital
- 12/12/22 Wells Fargo
- Wells Fargo downgrades Nevro to Equal Weight, lowers price target to $43
- $310.37 /
+2.085 (+0.68%) - 01/03/23 Wells Fargo
- Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
- 01/03/23 Wells Fargo
- Cigna downgraded to Equal Weight from Overweight at Wells Fargo
- 11/23/22 Morgan Stanley
- Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
- 11/23/22 Morgan Stanley
- Cigna assumed with an Overweight at Morgan Stanley
- 01/27/23 Lake Street
- Medavail price target lowered to $1 from $4 at Lake Street
- 01/12/23 Piper Sandler
- Oak Street could be worth over $49 per share in buyout, says Piper Sandler
- 01/12/23 Raymond James
- Raymond James upgrades Oak Street on potential takeout by CVS
- 01/10/23 Stifel
- Oak Street Health, CVS deal would make sense for both companies, says Stifel
- 01/04/23 Barclays
- Molina Healthcare price target lowered to $375 from $400 at Barclays
- 12/13/22 BofA
- Molina Healthcare upgraded to Neutral at BofA on 'high confidence' in EPS growth
- 12/13/22 BofA
- Molina Healthcare upgraded to Neutral from Underperform at BofA
- 11/07/22 Cowen
- Molina Healthcare price target raised to $380 from $371 at Cowen
- $485.76 /
-0.035 (-0.01%) - 01/13/23
- UnitedHealth backs FY23 adjusted EPS view $24.40-$24.90, consensus $24.94
- 01/13/23
- UnitedHealth reports Q4 adjusted EPS $5.34, consensus $5.17
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/26/22
- Molina Healthcare raises FY22 adjusted EPS view to at least $17.75 from $17.60
- 10/26/22
- Molina Healthcare reports Q3 adjusted EPS $4.36, consensus $4.21
- 11/02/22
- Humana backs FY22 adjusted EPS view 'approximately $25.00,' consensus $25.03
- 11/02/22
- Humana reports Q3 adjusted EPS $6.88, consensus $6.28
- 11/01/22
- Notable companies reporting before tomorrow's open
- 01/10/23
- CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
- 01/10/23
- CVS Health reaffirms FY22 adjusted EPS view $8.55-$8.65, consensus $8.63
- 11/02/22
- CVS Health sees FY23 adjusted EPS $8.70-$8.90, consensus $9.06
- 11/02/22
- CVS Health raises FY22 revenue view to $309B-$314B from $307B-$312B
- 01/03/23
- Centene raises 2024 adjusted EPS floor to $7.15 from $7.00
- 12/16/22
- Centene backs FY22 adjusted EPS view $5.65-$5.75, consensus $5.74
- 12/16/22
- Centene sees FY23 adjusted EPS $6.25-$6.40, consensus $6.34
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- $310.37 /
+2.085 (+0.68%) - 11/03/22
- Cigna raises FY22 adjusted EPS view to at least $23.10 from at least $22.90
- 11/03/22
- Cigna reports Q3 adjusted EPS $6.04, consensus $5.71
- 11/02/22
- Notable companies reporting before tomorrow's open
- $485.76 /
-0.035 (-0.01%) - 12/05/22
- Citron goes short Agilon, says Supreme Court 'torpedoed' business
- 11/16/22
- Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says
- 11/29/22
- Humana to shut down Jupiter, FL, facility, cut 150+ jobs, SFBJ reports
- 10/07/22
- Cano jumps after Bloomberg says CVS in exclusive buyout talks
- 09/22/22
- CVS Health said to weigh possible bid for Cano Health, Bloomberg says
- 01/19/23
- Rite Aid plans to provide abortion pill in some stores, Bloomberg reports
- 01/09/23
- CVS exploring $10B-plus takeover of Oak Street, Bloomberg says
- 01/09/23
- CVS Health exploring acquisition of Oak Street Health, Bloomberg reports
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 09/23/22
- Nebraska picks two current, one new Medicaid health plan provider, OWH reports
- 09/23/22
- UnitedHealth, Molina, Centene win Medicaid contracts in Nebraska, Bloomberg says
- 08/18/22
- White House plans for end of COVID-19 vaccine coverage, WSJ reports
- $310.37 /
+2.085 (+0.68%) - 01/27/23
- Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says
- 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- $485.76 /
-0.035 (-0.01%) - 01/13/23
- What You Missed On Wall Street On Friday
- 01/13/23
- What You Missed On Wall Street This Morning
- 11/29/22
- What You Missed On Wall Street On Tuesday
- 11/29/22
- What You Missed On Wall Street This Morning
- 10/03/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/18/22
- COVID vaccine makers under pressure as White House plans to end coverage
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/26/22
- What You Missed On Wall Street This Morning
- 10/26/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/23/22
- What You Missed On Wall Street On Friday
- 01/10/23
- What You Missed On Wall Street On Tuesday
- 01/10/23
- What You Missed On Wall Street This Morning
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 01/03/23
- What You Missed On Wall Street This Morning
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- $310.37 /
+2.085 (+0.68%) - 01/27/23
- What You Missed On Wall Street This Morning
- 11/23/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/03/22
- Fly Intel: Pre-market Movers
- $485.76 /
-0.035 (-0.01%) - 01/18/23
- Unusually active option classes on open January 18th
- 10/14/22
- Early notable gainers among liquid option names on October 14th
- 10/14/22
- Unusually active option classes on open October 14th
- 08/26/22
- Early notable gainers among liquid option names on August 26th
- 01/30/23
- Early notable gainers among liquid option names on January 30th
- 01/19/23
- Early notable gainers among liquid option names on January 19th
- 01/09/23
- Humana put volume heavy and directionally bearish
- 12/16/22
- Humana put volume heavy and directionally bearish
- 11/28/22
- CVS Health put volume heavy and directionally bearish
- 11/02/22
- Unusually active option classes on open November 2nd
- 10/19/22
- Unusually active option classes on open October 19th
- 09/13/22
- CVS Health call volume above normal and directionally bullish
- 01/17/23
- Centene call volume above normal and directionally bullish
- 01/09/23
- Centene put volume heavy and directionally bearish
- 12/22/22
- Early notable gainers among liquid option names on December 22nd
- 11/21/22
- Centene put volume heavy and directionally bearish
- $310.37 /
+2.085 (+0.68%) - 01/13/23
- Early notable gainers among liquid option names on January 13th
|